The use of thrombus precursor protein, D-dimer, prothrombin fragment 1.2, and thrombin antithrombin in the exclusion of proximal deep vein thrombosis and pulmonary embolism

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 4, 2000, Pages 371-377

  LaCapra, S ^a   Arkel, Yale S ^b   Ku, D H ^b   Gibson, D ^a   Lake, C ^a   Lam, X ^a  

^a OVERLOOK HOSPITAL   (United States)

^b Maine Medical Center Research Institute   (United States)

Author keywords

Coagulation activation markers; Deep vein thrombosis; Pulmonary embolism; Thrombus precursor protein

Indexed keywords

D DIMER; PROTEIN PRECURSOR; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBINS; BIOLOGICAL MARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; PROTHROMBIN; PULMONARY EMBOLISM; THROMBIN; THROMBOPHLEBITIS;

EID: 0034045987     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200006000-00009     Document Type: Article

References (20)

1. 1. Cranley JJ, Canos AJ, Sull WJ. The diagnosis of deep venous thrombosis. Fallibility of clinical symptoms and signs. Arch Surg 1976; 111: 34-36.
2. 2. Koopman MM, Van Beek EJ, ten Cate JW. Diagnosis of deep vein thrombosis. Prog Cardiovasc Dis 1994; 37: 1-12.
3. 3. Cogo A, Lensing AWA, Wells P, Prandoni P, Büller HR. Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis. Haemostasis 1995; 25: 27-39.
4. 4. van den Ende A, van Beek EJR, Brandjes DPM, Bossuyt PMM, Buller HR. Plasma D-dimer concentration in the exclusion of pulmonary embolism: a cost-effective approach? (Letter). Thromb Haemost 1995; 73: 1099.
5. 5. Speiser W, Mallek R, Koppensteiner R, Stumpflen A, Kapiotis S, Minar E, et al. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgment of anticoagulant treatment effectiveness. Thromb Haemost 1990; 64:196-201.
6. 6. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D, et al. Non-invasive diagnosis of venous thromboembolism in outpatients. The Lancet 1999; 353: 190-195.
7. 7. Charles LA, Edwards T, Macik BG. Evaluation of sensitivity and specificity of six D-dimer latex assay. Arch Pathol Lab Med 1994; 118: 1102-1105.
8. 8. Janssen MCH, Heebels AE, de Metz M, Verbruggen H, Wollersheim H, Janssen S, et al. Reliability of five rapid D-Dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost 1997; 77: 262-266.
9. 9. Niewenhuizen W. Soluble fibrin as a molecular marker for a pre-thrombotic state: a mini-review. Blood Coag Fibrinol 1993; 4: 93-96.
10. 10. Wieding JU, Hosius C. Determination of soluble fibrin: a comparison of four different methods. Thromb Res 1992; 65: 745-756.
11. 11. Gargan PE, Gaffney PJ, Pleasants JR, Ploplis VA. A monoclonal antibody which recognizes an epitopic region unique to the intact fibrin polymeric structure. Fibrinolysis 1993; 7: 275-283.
12. 12. Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-159.
13. 13. Bauer KA, Broekmans AW, Bertina RM, Conard J, Horellou MH, Samama MM, et al. Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood 1988; 71: 1418-1426.
14. 14. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-106.
15. 15. Hoek JA, Sturk A, ten-cate JW, Lamping RJ, Berends F, Borm JJ. Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes. Clin Chem 1988; 34: 2058-2062.
16. 16. Gaffney PJ, Joe F, Mahmoud M. Giant fibrin fragments derived from crosslinked fibrin: structure and clinical implication. Thromb Res 1980; 20: 647-662.
17. 17. Soria J, Soria C, Boucheix C, Mirshahi M, Perrot JY, Bernadou A, et al. Monoclonal antibodies that react preferentially with fibrinogen degradation products or with cross-linked fibrin split products. Ann New York Acad Sci 1983; 408: 665-666.
18. 18. Scarano L, Prandoni P, Gavasso S, Gomiero W, Garraro G, Girolami A. Failure of soluble fibrin polymers in the diagnosis of clinical suspected deep venous thrombosis. Blood Coag Fibrinol 1999; 10: 245-250.
19. 19. Bates SM, Grand'Maison A, Johnston M, McGrath J, Ginsberg JS. Use of the thrombus precursor protein (TpP) to exclude deep vein thrombosis [abstract]. Thromb Haemost 1999; 82(suppl 1): 259.
20. 20. Agnelli G. Prevention of venous thromboembolism after neurosurgery. Thromb Haemost 1999; 82: 925-930.